JPRN-UMIN000002317已完成3 期
A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L) - A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 1,319 人开始时间: 2009年8月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,319
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active bacterial or fungous infection. 2) Simultaneous or metachronous (within the past 5 years) double cancers. 3) Women during pregnancy or breast-feeding. 4) Interstitial pneumonitis, pulmonary fibrosis, or severe pulmonary emphysema. 5) Psychosis. 6) Systemic steroids medication. 7) Uncontrollable diabetes mellitus. 8) Uncontrollable hypertension. 9) History of severe heart disease, heart failure, myocardial infarction within the past 6 months or attack of angina pectoris within the past 6 months.
研究者
相似试验
进行中（未招募）
3 期
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung CancerLung CancerNCT00499330Alliance for Clinical Trials in Oncology701
已完成
不适用
Surgery versus no surgery of residual disease in patients with metastatic gastro-intestinal stromal tumourCancerISRCTN63599281European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)350
尚未招募
2 期
A phase ll study of robot assisted lobectomy for lung cancerlung cancerJPRN-UMIN000016270Shizuoka Cancer Center Hospital10
已完成
3 期
Phase III trial of upfront debulking surgery vs. neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers (JCOG0602, OV-NACTC-P3)stage III/IV mullerian carcinomas such as ovarian, tubal and peritoneal carcinomasJPRN-UMIN000000523Japan Clinical Oncology Group(JCOG)300
尚未招募
3 期
A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to imatinib mesylateGastro-intestinal stromal tumour (GIST)Cancer - Other cancer typesACTRN12609000681257European Organisation for Research and Treatment of Cancer (EORTC)350